These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31437412)

  • 1. Choice of intrathecal drug in the treatment of neuropathic pain - new research and opinion.
    Deer TR; Malinowski M; Varshney V; Pope J
    Expert Rev Clin Pharmacol; 2019 Oct; 12(10):1003-1007. PubMed ID: 31437412
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors to consider in the choice of intrathecal drug in the treatment of neuropathic pain.
    Deer TR; Pope JE
    Expert Rev Clin Pharmacol; 2015; 8(5):507-10. PubMed ID: 26294072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful reduction of neuropathic pain associated with spinal cord injury via of a combination of intrathecal hydromorphone and ziconotide: a case report.
    Saulino M
    Spinal Cord; 2007 Nov; 45(11):749-52. PubMed ID: 17310258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ziconotide infusion for severe chronic pain: case series of patients with neuropathic pain.
    Wermeling DP; Berger JR
    Pharmacotherapy; 2006 Mar; 26(3):395-402. PubMed ID: 16503720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ziconotide for spinal cord injury-related pain.
    Brinzeu A; Berthiller J; Caillet JB; Staquet H; Mertens P
    Eur J Pain; 2019 Oct; 23(9):1688-1700. PubMed ID: 31233255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic intrathecal drug administration for the control of intractable pain].
    Taira T
    Brain Nerve; 2008 May; 60(5):509-17. PubMed ID: 18516973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal Pain Therapy for the Management of Chronic Noncancer Pain.
    Sukul VV
    Neurosurg Clin N Am; 2019 Apr; 30(2):195-201. PubMed ID: 30898270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute rhabdomyolysis in a patient with long-term exposure to intrathecal ziconotide: a case report.
    Horazeck C; Huh AS; Huh BK
    Pain Pract; 2015 Mar; 15(3):E34-9. PubMed ID: 25565390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal drug delivery for pain management: recent advances and future developments.
    Jain S; Malinowski M; Chopra P; Varshney V; Deer TR
    Expert Opin Drug Deliv; 2019 Aug; 16(8):815-822. PubMed ID: 31305165
    [No Abstract]   [Full Text] [Related]  

  • 10. The Polyanalgesic Consensus Conference (PACC): Recommendations for Intrathecal Drug Delivery: Guidance for Improving Safety and Mitigating Risks.
    Deer TR; Pope JE; Hayek SM; Lamer TJ; Veizi IE; Erdek M; Wallace MS; Grider JS; Levy RM; Prager J; Rosen SM; Saulino M; Yaksh TL; De Andrés JA; Abejon Gonzalez D; Vesper J; Schu S; Simpson B; Mekhail N
    Neuromodulation; 2017 Feb; 20(2):155-176. PubMed ID: 28042914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ziconotide: new drug. Limited analgesic efficacy, too many adverse effects.
    Prescrire Int; 2008 Oct; 17(97):179-82. PubMed ID: 19530373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal ziconotide for neuropathic pain: a review.
    Rauck RL; Wallace MS; Burton AW; Kapural L; North JM
    Pain Pract; 2009; 9(5):327-37. PubMed ID: 19682321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic neuropathic pain in patients with spinal cord injury. What is the efficacy of regional interventions? Sympathetic blocks, nerve blocks and intrathecal drugs.
    Bensmail D; Ecoffey C; Ventura M; Albert T;
    Ann Phys Rehabil Med; 2009 Mar; 52(2):142-8. PubMed ID: 19909704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful Management of Corneal Neuropathic Pain with Intrathecal Targeted Drug Delivery.
    Hayek SM; Sweet JA; Miller JP; Sayegh RR
    Pain Med; 2016 Jul; 17(7):1302-7. PubMed ID: 26814286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal Therapy for Cancer-Related Pain.
    Bruel BM; Burton AW
    Pain Med; 2016 Dec; 17(12):2404-2421. PubMed ID: 28025375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Polyanalgesic Consensus Conference (PACC): Recommendations on Intrathecal Drug Infusion Systems Best Practices and Guidelines.
    Deer TR; Pope JE; Hayek SM; Bux A; Buchser E; Eldabe S; De Andrés JA; Erdek M; Patin D; Grider JS; Doleys DM; Jacobs MS; Yaksh TL; Poree L; Wallace MS; Prager J; Rauck R; DeLeon O; Diwan S; Falowski SM; Gazelka HM; Kim P; Leong M; Levy RM; McDowell G; McRoberts P; Naidu R; Narouze S; Perruchoud C; Rosen SM; Rosenberg WS; Saulino M; Staats P; Stearns LJ; Willis D; Krames E; Huntoon M; Mekhail N
    Neuromodulation; 2017 Feb; 20(2):96-132. PubMed ID: 28042904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biphasic effects of chronic intrathecal gabapentin administration on the expression of protein kinase C gamma in the spinal cord of neuropathic pain rats.
    Yeh CY; Chung SC; Tseng FL; Tsai YC; Liu YC
    Acta Anaesthesiol Taiwan; 2011 Dec; 49(4):144-8. PubMed ID: 22221687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ziconotide intrathecal delivery as treatment for secondary therapeutic failure of motor cortex stimulation after 6 years.
    Voirin J; Darie I; Fischer D; Simon A; Rohmer-Heitz I; Proust F
    Neurochirurgie; 2016 Oct; 62(5):284-288. PubMed ID: 27771111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidation of pathophysiology and treatment of neuropathic pain.
    Vranken JH
    Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):304-14. PubMed ID: 23033930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal drug administration in chronic pain syndromes.
    Ver Donck A; Vranken JH; Puylaert M; Hayek S; Mekhail N; Van Zundert J
    Pain Pract; 2014 Jun; 14(5):461-76. PubMed ID: 24118774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.